Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federica Perrone

Showing results (1-10 of 160) with videos related to

Pageof 16
Sort By:
World Journal of Gastroenterology|November 26, 2008
Clear cell adenocarcinoma of the colon is a unique morphological variant of intestinal carcinoma: case report with molecular analysisMarta Barisella, Andrea Lampis, Federica Perrone, et al.
Genes|November 11, 2022
Current Diagnostic Methods and Non-Coding RNAs as Possible Biomarkers in Huntington's DiseaseMiguel Pellegrini, Guendalina Bergonzoni, Federica Perrone, et al.
Acta Cytologica|August 28, 2007
Neuroendocrine small cell carcinoma of the cervix associated with endocervical adenocarcinoma: a case reportClaudia Alphandery, Gianpaolo Dagrada, Milo Frattini, et al.
Genome Medicine|April 15, 2021
Emerging genetic complexity and rare genetic variants in neurodegenerative brain diseasesFederica Perrone, Rita Cacace, Julie van der Zee, et al.
Oncotarget|August 25, 2016
Prognostic and predictive value of EGFR in head and neck squamous cell carcinomaPaolo Bossi, Carlo Resteghini, Nicholas Paielli, et al.
The American Journal of Surgical Pathology|September 25, 2013
Frequent mutation and nuclear localization of β-catenin in sertoli cell tumors of the testisFederica Perrone, Alessia Bertolotti, Gabriella Montemurro, et al.
Molecular Oncology|November 17, 2009
Targeted therapies: the rare cancer paradigmMarco A Pierotti, Tiziana Negri, Elena Tamborini, et al.
Cellular Signalling|February 16, 2008
PTPRK negatively regulates transcriptional activity of wild type and mutated oncogenic beta-catenin and affects membrane distribution of beta-catenin/E-cadherin complexes in cancer cellsLuisa Novellino, Annamaria De Filippo, Paola Deho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2010
TP53 mutations and pathologic complete response to neoadjuvant cisplatin and fluorouracil chemotherapy in resected oral cavity squamous cell carcinomaFederica Perrone, Paolo Bossi, Barbara Cortelazzi, et al.
International Journal of Radiation Oncology, Biology, Physics|July 7, 2009
Oropharyngeal squamous cell carcinoma treated with radiotherapy or radiochemotherapy: prognostic role of TP53 and HPV statusCarlo Fallai, Federica Perrone, Lisa Licitra, et al.
Pageof 16

Showing results (1-10 of 160) with videos related to

Sort By:
Pageof 16
World Journal of Gastroenterology|November 26, 2008
Clear cell adenocarcinoma of the colon is a unique morphological variant of intestinal carcinoma: case report with molecular analysisMarta Barisella, Andrea Lampis, Federica Perrone, et al.
Genes|November 11, 2022
Current Diagnostic Methods and Non-Coding RNAs as Possible Biomarkers in Huntington's DiseaseMiguel Pellegrini, Guendalina Bergonzoni, Federica Perrone, et al.
Acta Cytologica|August 28, 2007
Neuroendocrine small cell carcinoma of the cervix associated with endocervical adenocarcinoma: a case reportClaudia Alphandery, Gianpaolo Dagrada, Milo Frattini, et al.
Genome Medicine|April 15, 2021
Emerging genetic complexity and rare genetic variants in neurodegenerative brain diseasesFederica Perrone, Rita Cacace, Julie van der Zee, et al.
Oncotarget|August 25, 2016
Prognostic and predictive value of EGFR in head and neck squamous cell carcinomaPaolo Bossi, Carlo Resteghini, Nicholas Paielli, et al.
The American Journal of Surgical Pathology|September 25, 2013
Frequent mutation and nuclear localization of β-catenin in sertoli cell tumors of the testisFederica Perrone, Alessia Bertolotti, Gabriella Montemurro, et al.
Molecular Oncology|November 17, 2009
Targeted therapies: the rare cancer paradigmMarco A Pierotti, Tiziana Negri, Elena Tamborini, et al.
Cellular Signalling|February 16, 2008
PTPRK negatively regulates transcriptional activity of wild type and mutated oncogenic beta-catenin and affects membrane distribution of beta-catenin/E-cadherin complexes in cancer cellsLuisa Novellino, Annamaria De Filippo, Paola Deho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2010
TP53 mutations and pathologic complete response to neoadjuvant cisplatin and fluorouracil chemotherapy in resected oral cavity squamous cell carcinomaFederica Perrone, Paolo Bossi, Barbara Cortelazzi, et al.
International Journal of Radiation Oncology, Biology, Physics|July 7, 2009
Oropharyngeal squamous cell carcinoma treated with radiotherapy or radiochemotherapy: prognostic role of TP53 and HPV statusCarlo Fallai, Federica Perrone, Lisa Licitra, et al.
Pageof 16